Dysbiosis in Pathogenesis of Inflammatory Bowel Disease and Ankylosing Spondylitis

Dysbiosis in Pathogenesis of Inflammatory Bowel Disease and Ankylosing Spondylitis

According to data published in Arthritis Research & Therapy, patients with IBD and Ankylosing Spondylitis (AS) have distinct microbial compositions. In individuals who are genetically susceptible, a imbalanced gut microbiome may play a key role in initiating and triggering the immune system. Aberrations in the gut microbiome have consistently and repeatedly been shown in patients with IBD. This includes decreased diversity and increase in pro-inflammatory bacterial species. In addition, 87 % of patients with AS had a higher level of an inflammatory marker called fecal calprotectin and a lower abundance of F. Prau. The trademarked prebiotics in Gut Food and Repair by Biome and Beyond have been clinically proven to increase levels of F. Prau and reverse dysbiosis. Please visit us today for more info at www.Biomebeyond.com # Dysbiosis #Inflammatory Bowel Disease #Gut Microbiome # Prebiotics # leaky Gut#Crohns and Colitis #Ankylosing Spondylitis

Back to blog